446 related articles for article (PubMed ID: 27566410)
1. Dysregulation of the (immuno)proteasome pathway in malformations of cortical development.
van Scheppingen J; Broekaart DW; Scholl T; Zuidberg MR; Anink JJ; Spliet WG; van Rijen PC; Czech T; Hainfellner JA; Feucht M; Mühlebner A; van Vliet EA; Aronica E
J Neuroinflammation; 2016 Aug; 13(1):202. PubMed ID: 27566410
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of (immuno)proteasome subunits during epileptogenesis is attenuated by inhibition of the mammalian target of rapamycin pathway.
Broekaart DWM; van Scheppingen J; Geijtenbeek KW; Zuidberg MRJ; Anink JJ; Baayen JC; Mühlebner A; Aronica E; Gorter JA; van Vliet EA
Epilepsia; 2017 Aug; 58(8):1462-1472. PubMed ID: 28643873
[TBL] [Abstract][Full Text] [Related]
3. Impaired oligodendroglial turnover is associated with myelin pathology in focal cortical dysplasia and tuberous sclerosis complex.
Scholl T; Mühlebner A; Ricken G; Gruber V; Fabing A; Samueli S; Gröppel G; Dorfer C; Czech T; Hainfellner JA; Prabowo AS; Reinten RJ; Hoogendijk L; Anink JJ; Aronica E; Feucht M
Brain Pathol; 2017 Nov; 27(6):770-780. PubMed ID: 27750396
[TBL] [Abstract][Full Text] [Related]
4. Changes in vascular density in resected tissue of 97 patients with mild malformation of cortical development, focal cortical dysplasia or TSC-related cortical tubers.
Veersema TJ; de Neef A; van Scheppingen J; Ferrier CH; van Eijsden P; Gosselaar PH; van Rijen PC; Spliet WGM; Braun KPJ; Mühlebner A; Aronica E
Int J Dev Neurosci; 2019 Dec; 79():96-104. PubMed ID: 31770571
[TBL] [Abstract][Full Text] [Related]
5. Activation of leukocyte immunoglobulin-like receptor B2 signaling pathway in cortical lesions of pediatric patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
Yue J; Zhang C; Shi X; Wei Y; Liu L; Liu S; Yang H
Brain Dev; 2019 Nov; 41(10):829-838. PubMed ID: 31495513
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress and inflammation in a spectrum of epileptogenic cortical malformations: molecular insights into their interdependence.
Arena A; Zimmer TS; van Scheppingen J; Korotkov A; Anink JJ; Mühlebner A; Jansen FE; van Hecke W; Spliet WG; van Rijen PC; Vezzani A; Baayen JC; Idema S; Iyer AM; Perluigi M; Mills JD; van Vliet EA; Aronica E
Brain Pathol; 2019 May; 29(3):351-365. PubMed ID: 30303592
[TBL] [Abstract][Full Text] [Related]
7. mTOR-dependent abnormalities in autophagy characterize human malformations of cortical development: evidence from focal cortical dysplasia and tuberous sclerosis.
Yasin SA; Ali AM; Tata M; Picker SR; Anderson GW; Latimer-Bowman E; Nicholson SL; Harkness W; Cross JH; Paine SM; Jacques TS
Acta Neuropathol; 2013 Aug; 126(2):207-18. PubMed ID: 23728790
[TBL] [Abstract][Full Text] [Related]
8. mTOR pathway activation in focal cortical dysplasia.
Kumari K; Sharma MC; Kakkar A; Malgulwar PB; Pathak P; Suri V; Sarkar C; Chandra SP; Faruq M
Ann Diagn Pathol; 2020 Jun; 46():151523. PubMed ID: 32325422
[TBL] [Abstract][Full Text] [Related]
9. Cell injury and premature neurodegeneration in focal malformations of cortical development.
Iyer A; Prabowo A; Anink J; Spliet WG; van Rijen PC; Aronica E
Brain Pathol; 2014 Jan; 24(1):1-17. PubMed ID: 23586324
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression of fibroblast growth factor (FGF)-2 in epilepsy-associated malformations of cortical development (MCDs).
Sugiura C; Miyata H; Ueda M; Ohama E; Vinters HV; Ohno K
Neuropathology; 2008 Aug; 28(4):372-81. PubMed ID: 18179408
[TBL] [Abstract][Full Text] [Related]
11. Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia.
Talos DM; Sun H; Kosaras B; Joseph A; Folkerth RD; Poduri A; Madsen JR; Black PM; Jensen FE
Ann Neurol; 2012 Apr; 71(4):539-51. PubMed ID: 22447678
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of CD47 and CD200 in patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
Sun FJ; Zhang CQ; Chen X; Wei YJ; Li S; Liu SY; Zang ZL; He JJ; Guo W; Yang H
J Neuroinflammation; 2016 Apr; 13(1):85. PubMed ID: 27095555
[TBL] [Abstract][Full Text] [Related]
13. Elevated Expression of TRPC4 in Cortical Lesions of Focal Cortical Dysplasia II and Tuberous Sclerosis Complex.
Wang LK; Chen X; Zhang CQ; Liang C; Wei YJ; Yue J; Liu SY; Yang H
J Mol Neurosci; 2017 Jun; 62(2):222-231. PubMed ID: 28455787
[TBL] [Abstract][Full Text] [Related]
14. FCD Type II and mTOR pathway: Evidence for different mechanisms involved in the pathogenesis of dysmorphic neurons.
Rossini L; Villani F; Granata T; Tassi L; Tringali G; Cardinale F; Aronica E; Spreafico R; Garbelli R
Epilepsy Res; 2017 Jan; 129():146-156. PubMed ID: 28056425
[TBL] [Abstract][Full Text] [Related]
15. Doublecortin-like (DCL) expression in focal cortical dysplasia and cortical tubers.
Boer K; Lucassen PJ; Spliet WG; Vreugdenhil E; van Rijen PC; Troost D; Jansen FE; Aronica E
Epilepsia; 2009 Dec; 50(12):2629-37. PubMed ID: 19583781
[TBL] [Abstract][Full Text] [Related]
16. Expression of the Nogo-A system in cortical lesions of pediatric patients with tuberous sclerosis complex and focal cortical dysplasia type IIb.
Yu SX; Li S; Shu HF; Zhang CQ; Liu SY; Yang H
J Neuropathol Exp Neurol; 2012 Jul; 71(7):665-77. PubMed ID: 22710967
[TBL] [Abstract][Full Text] [Related]
17. Characteristic expression of p57/Kip2 in balloon cells in focal cortical dysplasia.
Kimura T; Kitaura H; Masuda H; Kameyama S; Saito Y; Sugai K; Otsuki T; Nakazawa A; Morota N; Yamamoto T; Iida K; Nakagawa M; Mizuno T; Takahashi H; Kakita A
Neuropathology; 2015 Oct; 35(5):401-9. PubMed ID: 25950494
[TBL] [Abstract][Full Text] [Related]
18. Expression patterns of synaptic vesicle protein 2A in focal cortical dysplasia and TSC-cortical tubers.
Toering ST; Boer K; de Groot M; Troost D; Heimans JJ; Spliet WG; van Rijen PC; Jansen FE; Gorter JA; Reijneveld JC; Aronica E
Epilepsia; 2009 Jun; 50(6):1409-18. PubMed ID: 19220410
[TBL] [Abstract][Full Text] [Related]
19. Activation of Toll-like receptor, RAGE and HMGB1 signalling in malformations of cortical development.
Zurolo E; Iyer A; Maroso M; Carbonell C; Anink JJ; Ravizza T; Fluiter K; Spliet WG; van Rijen PC; Vezzani A; Aronica E
Brain; 2011 Apr; 134(Pt 4):1015-32. PubMed ID: 21414994
[TBL] [Abstract][Full Text] [Related]
20. Expression of pannexin 1 and 2 in cortical lesions from intractable epilepsy patients with focal cortical dysplasia.
Li S; Zang Z; He J; Chen X; Yu S; Pei Y; Hou Z; An N; Yang H; Zhang C; Liu S
Oncotarget; 2017 Jan; 8(4):6883-6895. PubMed ID: 28036289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
